Top Markets
Coin of the day
EV Biologics, Inc. EV Biologics, Inc.

EV Biologics, Inc.

YECO
Rang in Aktien #42252
EV Biologics, Inc. is a biotechnology enterprise focused on the commercial... EV Biologics, Inc. is a biotechnology enterprise focused on the commercial advancement of extracellular vesicles (EVs), utilizing them as biological agents for diagnostic and therapeutic applications. The company capitalizes on its proprietary, versatile EV platform to engineer innovative vaccines, treatments, and potential cures. Beyond EVs, it also dedicates efforts to cultivating human mesenchymal and other stem cells, as well as various cell-derived products, to address the needs of the cosmetic and biopharmaceutical industries. Founded in 2011, the firm was originally known as Yulong Eco-Materials Limited until its rebranding to EV Biologics, Inc. in August 2020, and it operates from its headquarters in Cheyenne, Wyoming.
Aktienkurs
$0.0004
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$2.89K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-99.51%
Land
US
Handel EV Biologics, Inc. (YECO)

Kategorie

Dividendenhistorie für EV Biologics, Inc. (YECO)
EV Biologics, Inc. (Aktienkürzel: YECO) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für EV Biologics, Inc. (YECO) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
0.00%
US
0.00%
NL
0.00%
CH
29.00%
BE
0.00%
KR